IPath Series Competition

GRN Etf  USD 32.72  0.95  2.82%   
iPath Series B competes with Fidelity Real, Putnam ETF, Virtus Real, Advisors Inner, and First Trust; as well as few others. Analyzing IPath Series competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of IPath Series to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out IPath Series Correlation with its peers.

IPath Series vs YieldMax Correlation

Poor diversification

The correlation between iPath Series B and SDTY is 0.7 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding iPath Series B and SDTY in the same portfolio, assuming nothing else is changed.

Moving together with IPath Etf

  0.63GLD SPDR Gold Shares Aggressive PushPairCorr
  0.63IAU iShares Gold TrustPairCorr
  0.73SLV iShares Silver Trust Sell-off TrendPairCorr
  0.63GLDM SPDR Gold MiniPairCorr
  0.63SGOL abrdn Physical GoldPairCorr

Moving against IPath Etf

  0.83VXX iPath Series B Low VolatilityPairCorr
  0.83VIXY ProShares VIX Short Low VolatilityPairCorr
  0.78VIXM ProShares VIX Mid Low VolatilityPairCorr
  0.78VXZ iPath Series B Low VolatilityPairCorr
  0.75YCL ProShares Ultra YenPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
31.2032.7334.26
Details
Intrinsic
Valuation
LowRealHigh
31.5033.0334.56
Details
Naive
Forecast
LowNextHigh
30.4531.9833.51
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
32.7034.4636.22
Details

IPath Series Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between IPath Series and its competitors represents the degree of relationship between the price movements of corresponding etfs. A correlation of about +1.0 implies that the price of IPath and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of iPath Series B does not affect the price movement of the other competitor.

High positive correlations

UBERMSFT
XOMMRK
MRKF
JPMCRM
AT
XOMF
  

High negative correlations

MRKMSFT
MRKUBER
XOMMSFT
XOMT
TF
XOMA

IPath Series Competition Risk-Adjusted Indicators

There is a big difference between IPath Etf performing well and IPath Series ETF doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IPath Series' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
META  1.60 (0.03)(0.01) 0.02  2.40 
 3.43 
 13.02 
MSFT  1.24 (0.29) 0.00 (1.12) 0.00 
 1.85 
 4.90 
UBER  1.47 (0.24) 0.00 (0.26) 0.00 
 2.50 
 10.23 
F  1.47  0.18  0.10  0.52  1.32 
 3.65 
 16.30 
T  0.88 (0.03) 0.00 (0.14) 0.00 
 1.63 
 4.30 
A  1.19 (0.22) 0.00 (0.12) 0.00 
 2.90 
 7.85 
CRM  1.53 (0.30) 0.00 (0.24) 0.00 
 2.94 
 12.37 
JPM  1.11  0.04 (0.01)(0.50) 1.66 
 2.00 
 7.38 
MRK  1.26  0.30  0.21  0.47  1.14 
 3.59 
 8.09 
XOM  1.06  0.24  0.18  0.45  0.96 
 2.38 
 5.82 

IPath Series Competitive Analysis

The better you understand IPath Series competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, IPath Series' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across IPath Series' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
GRN FPRO PEMX VRAI RAYJ FTXH RBLD QQQD DTRE APRZ
 2.82 
 32.72 
IPath
 1.32 
 22.96 
Fidelity
 0.00 
 71.92 
Putnam
 1.06 
 24.88 
Virtus
 0.00 
 35.22 
Advisors
 0.56 
 33.62 
First
 0.11 
 79.59 
First
 0.39 
 12.93 
Direxion
 1.66 
 40.42 
First
 0.21 
 37.93 
TrueShares
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Equity Positions Weight
Three Year Return
Net Asset
Five Year Return
One Year Return
Last Dividend Paid
Ten Year Return
Price To Earning
Beta
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

IPath Series Competition Performance Charts

Five steps to successful analysis of IPath Series Competition

IPath Series' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by iPath Series B in relation to its competition. IPath Series' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of IPath Series in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact IPath Series' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to iPath Series B, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your IPath Series position

In addition to having IPath Series in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Corporate ETFs Thematic Idea Now

Corporate ETFs
Corporate ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Corporate ETFs theme has 191 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether iPath Series B offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IPath Series' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ipath Series B Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ipath Series B Etf:
Check out IPath Series Correlation with its peers.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Understanding iPath Series B requires distinguishing between market price and book value, where the latter reflects IPath's accounting equity. The concept of intrinsic value—what IPath Series' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push IPath Series' price substantially above or below its fundamental value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, IPath Series' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.